Noisy
← this week  ·  Subscribe →

The world is being quietly rearranged by people who write very long documents.

Federal Register · August 21, 2025
The title they went with Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Pharmacogenetic Assessment System Noisy translates that to

Genetic tests that predict drug response can now get to market faster

What happened
US health regulators just made it easier to bring genetic tests for drug response to market. This means manufacturers face fewer hurdles, and patients might get access to these tools sooner.
Why it matters
New medical devices that did not fit existing categories often faced the highest level of regulatory scrutiny by default. This rule creates a specific, less burdensome path for genetic tests that predict how patients will react to drugs. It means companies can develop and sell these tools more easily, making personalized medicine more common.
The signal
Watch for an increase in the number of these genetic drug response tests approved and available to doctors and patients in the next 12-24 months.
If you insist
Read the original →